Literature DB >> 8794395

Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression.

M Guan1, R D Zhang, B Wu, E E Henderson.   

Abstract

CD4+ and CD8+ T lymphocytes purified from normal adult donors by flow cytometry could be infected with Epstein-Barr virus (EBV) as measured by the accumulation of components of the EBV replicative cycle, viral DNA and viral transcripts encoding EBER1 and BRLF1. EBV infection resulted in enhanced replication of human immunodeficiency virus type 1 (HIV-1) IIIB in CD4+ lymphocytes as measured by accumulation of reverse transcriptase and formation of syncytia. Furthermore, a small percentage of CD8+ T cells became permissive after infection with EBV. Inactivation of transforming functions by irradiation with UV light greatly reduced the ability of EBV to enhance HIV-1 replication in T4+ T cell, suggesting that live virus is needed for enhancement. These results demonstrate a direct synergy between EBV and HIV-1 during coinfection of T cells in vitro and may explain the beneficial effect of acyclovir in combination with antiretroviral chemotherapy as well as the increased incidence of T-cell lymphomas associated with EBV in patients with AIDS.

Entities:  

Mesh:

Year:  1996        PMID: 8794395      PMCID: PMC190801     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes.

Authors:  E Fischer; C Delibrias; M D Kazatchkine
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

2.  Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes.

Authors:  G Sauvageau; R Stocco; S Kasparian; J Menezes
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

3.  Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.

Authors:  J Sample; L Young; B Martin; T Chatman; E Kieff; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Detection of Epstein-Barr virus genome in benign polyclonal proliferative T cells of a young male patient.

Authors:  N Yoneda; E Tatsumi; M Kawanishi; K Teshigawara; S Masuda; Y Yamamura; A Inui; G Yoshino; M Oimomi; S Baba
Journal:  Blood       Date:  1990-07-01       Impact factor: 22.113

5.  Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations.

Authors:  E E Henderson; J Y Yang; R D Zhang; M Bealer
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

6.  Loss of human CR1- and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations.

Authors:  M H Holguin; C B Kurtz; C J Parker; J J Weis; J H Weis
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

7.  Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus.

Authors:  I Joab; H Triki; J de Saint Martin; M Perricaudet; J C Nicolas
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

8.  Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism.

Authors:  C M Walker; A L Erickson; F C Hsueh; J A Levy
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion.

Authors:  A Schattner; N Hanuka; B Sarov; I Sarov; Z Handzel; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

10.  CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals.

Authors:  C M Walker; D J Moody; D P Stites; J A Levy
Journal:  Cell Immunol       Date:  1989-04-01       Impact factor: 4.868

View more
  1 in total

1.  Comparison of the effect of semen from HIV-infected and uninfected men on CD4+ T-cell infection.

Authors:  Céline Camus; Giulia Matusali; Olivier Bourry; Dominique Mahe; Florence Aubry; Louis Bujan; Christophe Pasquier; Patrice Massip; Célia Ravel; Onofrio Zirafi; Jan Munch; Nadia R Roan; Charles Pineau; Nathalie Dejucq-Rainsford
Journal:  AIDS       Date:  2016-05-15       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.